Blue Rock Advisors’s NEVRO CORP. NVRO Stock Holding History

Blue Rock Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,926	Closed	-$686K	–	97
2020 Q3	$686K	Buy	+4,926	New	+$658K	0.59%	65

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Blue Rock Advisors's NVRO Position: Q4 2020 in Review

Blue Rock Advisors sold out of NEVRO CORP. (NVRO) in Q4 2020, closing a stake of 4,926 shares — an estimated $686K sold.

Blue Rock Advisors first reported a position in NVRO in Q3 2020 and held it in 1 quarter. The position peaked at $686K in Q3 2020. 226 funds tracked by Wall St. Rank hold NVRO as of Q4 2020.

Blue Rock Advisors reported no remaining NEVRO CORP. position as of Q4 2020 after selling out during the quarter.
Blue Rock Advisors sold 4,926 NEVRO CORP. shares in Q4 2020, an estimated $686K.
Blue Rock Advisors first reported a position in NEVRO CORP. in Q3 2020 and held it in 1 quarter.
Blue Rock Advisors's NEVRO CORP. position peaked at $686K in Q3 2020.
226 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2020.

Based on Blue Rock Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.